Entecavir Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Entecavir Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: entecavir
Brand name: Baraclude
Synonyms: Entecavir
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Entecavir Tablets-Insulin degludec
- Entecavir Tablets-Insulin Degludec (U-100) Prefilled Pens
- Entecavir Tablets-Insulin Degludec (U-100) Vials
- Entecavir Tablets-Insulin Degludec (U-200) Prefilled Pens
- Entecavir Tablets-Insulin degludec and liraglutide
- Entecavir Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Entercote
- Insulin aspart, recombinant Subcutaneous-Entereg
- Insulin aspart, recombinant Subcutaneous-Entex
- Insulin aspart, recombinant Subcutaneous-Entex HC
- Insulin aspart, recombinant Subcutaneous-Entex PSE
- Insulin aspart, recombinant Subcutaneous-Entex T